Procaps (PROC) - Nilai pasar

Simbol resmi perusahaan Procaps Group Corp (PROC)

The asset value of Procaps Group S.A. (PROC), currently at 0.11 as shown on the chart, is based on the company's leadership in softgel production in Latin America and its pricing power over industry behemoths. The business relies on an autonomous development cycle, making it resilient to global crises and a reliable defensive asset. High trust from global partners is ensured by the impeccable quality of its contract manufacturing.

Procaps - Biji pasar PROC (periode 04.07.2022 - 16.02.2025)

Rincian metrik komprehensif lan analitis Procaps Group Corp (PROC)

Indikator keuangan lan pasar perusahaan Procaps Group S.A. (PROC):
Analisis fundamental perusahaan:PROC (Procaps)
Sampel barang Procaps Group Corp

Investors are seeking fundamental benchmarks in the financial statements of Procaps Group S.A. (PROC) to assess business value. Market capitalization measures the total value of all shares, reflecting current market demand for the assets. Analyzing the issuer's aggregate market value allows for the real-time tracking of price fluctuations between quarterly reports. The robotization of pharmaceutical plants reduces operating expenses, directly impacting investment attractiveness. The stability of the curve confirms the efficiency of automated production.

Pesaing wigati

Nilai pasar Haleon HLN|Nilai pasar KVUE|VRNA - Nilai pasar|Nilai pasar Jyong Bio|LGND: Kapitalisasi pasar|Biji pasar amneal.com|Nilai pasar Perrigo|Alvotech S.A. - Biji pasar|Kapitalisasi pasar LQDA|GLPG (Galapagos Corp) - Nilai pasar|Kapitalisasi pasar ANIP (ANI Pharmaceuticals)|Kapitalisasi pasar mannkindcorp.com MNKD|AMPH - Nilai pasar|Nilai pasar PCRX (Pacira Pharmaceuticals)|ARS Pharma (SPRY) - Nilai pasar|Biji pasar Theravance Corp|AQST (Aquestive Therapeutics) - Kapitalisasi pasar|Kapitalisasi pasar scPharma|Biji pasar TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharma) - Nilai pasar|Nilai pasar China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. (EPRX) - Nilai pasar|BHST: Biji pasar|invizyne.com - Nilai pasar|ORMP: Kapitalisasi pasar|Entera Bio - Nilai pasar|HYFT (MindWalk) - Kapitalisasi pasar|Nilai pasar ABVC BioPharma, Inc ABVC|Nilai pasar Cumberland Pharmaceuticals (CPIX)|QNTM (quantumbiopharma.com) - Nilai pasar|Nilai pasar FibroGen FGEN|TELO (Telomir Pharmaceuticals Inc) - Biji pasar|RANI - Nilai pasar|Nilai pasar SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Nilai pasar|Nilai pasar Lexaria Bioscience Corp. (LEXX)|PULM (Pulmatrix) - Kapitalisasi pasar|Biji pasar Pheton (PTHL)|Kapitalisasi pasar APM|Kapitalisasi pasar Lyra Therapeutics Inc (LYRA)|Nilai pasar Impact BioMedical IBO|TNFA (TNF Pharmaceuticals Inc.) - Biji pasar|YCBD - Nilai pasar|Kapitalisasi pasar PainReform Ltd PRFX|CYTO (altamiratherapeutics.com) - Biji pasar|Lipella Pharma - Nilai pasar|OPTN (OptiNose, Inc.) - Kapitalisasi pasar|PIRS - Kapitalisasi pasar|Nilai pasar Petros Pharmaceuticals, Inc. (PTPI)|QLI (Qilian International Holding Group) - Nilai pasar|Nilai pasar ACELYRIN, Inc. SLRN|TFF Pharmaceuticals, Inc (TFFP) - Nilai pasar